Company news
Carlsmed, Inc. (NASDAQ:CARL) news
Carlsmed, Inc. news releases on 6ix. Latest, Oct 2, 2026: Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press releases & updates
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2026
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
September 30, 2026
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
September 28, 2026
Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical
September 15, 2026
Carlsmed, Inc. Announces Chief Operating Officer Appointment
September 8, 2026
Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance
August 5, 2026
Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures
August 3, 2026
Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
Carlsmed® Reports First Quarter 2026 Financial Results
May 5, 2026
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
April 28, 2026
Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026
April 14, 2026
Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference
March 31, 2026
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results
February 25, 2026
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference
February 22, 2026
Carlsmed Announces first corra™ personalized Cervical Plating Procedure
February 18, 2026
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
February 11, 2026
Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure
February 10, 2026
Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
January 12, 2026
Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal
January 6, 2026
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference
December 15, 2025
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting
December 3, 2025
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference
November 18, 2025
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance
November 6, 2025
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025
October 23, 2025
Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary
September 29, 2025
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index
September 22, 2025
UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results
August 28, 2025
Carlsmed® Reports Second Quarter 2025 Financial Results
August 28, 2025
Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025
August 14, 2025
Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures
August 1, 2025
Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery
July 28, 2025
Carlsmed Announces Pricing of Initial Public Offering
July 22, 2025
Carlsmed Announces Launch of Initial Public Offering
July 22, 2025